Sage Therapeutics Inc. (SAGE)
NASDAQ: SAGE
· Real-Time Price · USD
8.68
0.00 (0.00%)
At close: Jul 30, 2025, 3:59 PM
Sage Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 31.66M | 14.06M | 12.82M | 11.87M | 8.65M | 7.9M | 77.97M | 2.72M | 2.47M | 3.29M | 2.87M | 1.74M | 1.5M | 1.58M | 1.64M | 1.44M | 1.64M | 1.58M |
Cost of Revenue | -55K | 655K | 1.49M | 5.28M | 1.41M | 1.27M | 820K | 905K | 205K | 230K | 143K | 184K | 200K | 286K | 87K | 131K | 148K | 187K |
Gross Profit | 31.71M | 13.41M | 11.33M | 6.59M | 7.25M | 6.63M | 77.15M | 1.81M | 2.27M | 3.06M | 2.72M | 1.55M | 1.3M | 1.3M | 1.55M | 1.31M | 1.5M | 1.4M |
Operating Income | -53.97M | -67.45M | -102.19M | -101.2M | -111.3M | -117.08M | -42.07M | -211.85M | -170.46M | -155.47M | -153.9M | -141.48M | -128.41M | -123.2M | -125.49M | -130.89M | -108.02M | -96.51M |
Interest Income | 4.32M | n/a | 6.4M | 7.64M | 8.43M | 9.2M | 9.47M | 10.27M | 10.17M | 8.83M | 6.79M | 4.13M | 2.1M | 1.17M | 751K | 692K | 732K | 708K |
Pretax Income | -49.65M | -62.21M | -95.78M | -93.55M | -102.85M | -108.48M | -32.71M | -201.63M | -160.32M | -146.83M | -147.15M | -137.32M | -126.26M | -122.06M | -124.71M | -130.17M | -107.25M | -95.76M |
Net Income | -49.65M | -62.21M | -95.78M | -93.55M | -102.85M | -108.48M | -32.71M | -201.63M | -160.32M | -138.19M | -133.31M | -129.04M | -122.01M | -119.74M | -124.71M | -130.17M | -107.25M | -95.76M |
Selling & General & Admin | 62M | 57.59M | 54.65M | 53.22M | 55.98M | 51.98M | 55.11M | 78.14M | 75.56M | 65.71M | 67.33M | 61.48M | 52.41M | 46.48M | 51.6M | 48.71M | 43.35M | 39.85M |
Research & Development | 23.92M | 22.76M | 37.02M | 54.58M | 62.56M | 71.73M | 64.33M | 101.92M | 97.16M | 92.83M | 89.3M | 81.55M | 77.3M | 78.02M | 75.44M | 83.5M | 66.17M | 58.06M |
Other Expenses | -230K | 513K | 21.86M | n/a | 15K | -12K | -99K | -55K | -41K | -188K | -37K | 30K | 45K | -24K | 24K | 31K | 44K | 35K |
Operating Expenses | 85.68M | 80.86M | 113.52M | 107.8M | 118.55M | 123.71M | 119.44M | 180.06M | 172.73M | 158.53M | 156.62M | 143.03M | 129.71M | 124.5M | 127.04M | 132.2M | 109.52M | 97.9M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -597K | n/a | n/a | 76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 85.63M | 81.52M | 115.01M | 113.07M | 119.95M | 124.98M | 120.26M | 180.97M | 172.93M | 158.76M | 156.77M | 143.22M | 129.91M | 124.78M | 127.13M | 132.33M | 109.66M | 98.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 292.72K | n/a | n/a | n/a | -8.64M | -13.84M | -8.28M | -4.25M | -2.31M | -1.08M | -692K | -732K | -708K |
Shares Outstanding (Basic) | 62.61M | 61.86M | 60.77M | 61.12M | 60.54M | 60.14M | 59.99M | 59.91M | 59.77M | 59.67M | 59.49M | 59.43M | 59.27M | 58.96M | 58.9M | 58.82M | 58.58M | 58.37M |
Shares Outstanding (Diluted) | 62.61M | 61.86M | 60.77M | 61.12M | 60.54M | 60.14M | 59.99M | 59.91M | 59.77M | 59.67M | 59.49M | 59.43M | 59.27M | 59.03M | 58.9M | 58.82M | 58.58M | 58.37M |
EPS (Basic) | -0.79 | -1.01 | -1.57 | -1.53 | -1.7 | -1.8 | -0.55 | -3.37 | -2.68 | -2.32 | -2.24 | -2.17 | -2.06 | -2.03 | -2.12 | -2.21 | -1.83 | -1.64 |
EPS (Diluted) | -0.79 | -1.01 | -1.57 | -1.53 | -1.7 | -1.8 | -0.55 | -3.37 | -2.68 | -2.32 | -2.24 | -2.17 | -2.06 | -2.03 | -2.12 | -2.21 | -1.83 | -1.64 |
EBITDA | -54.09M | -67.45M | -80.21M | -101.2M | -110.99M | -117.34M | -41.88M | -177.92M | -170.13M | -155.15M | -153.61M | -141.2M | -128.13M | -122.92M | -125.15M | -130.52M | -107.13M | -93.92M |
EBIT | -54.2M | -66.94M | -80.34M | -101.2M | -111.3M | -117.67M | -42.29M | -178.25M | -170.46M | -155.47M | -153.9M | -141.48M | -128.44M | -123.2M | -125.49M | -130.89M | -108.02M | -96.51M |
Depreciation & Amortization | 104K | 112K | 129K | 255K | 311K | 336K | 409K | 330K | 331K | 323K | 290K | 278K | 279K | 275K | 333K | 400K | 900K | 2.58M |